May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Influence of Lutein Dosage on Macular Pigment Response
Author Affiliations & Notes
  • J.T. Landrum
    Chemistry,
    Florida International Univ, Miami, FL
  • R.A. Bone
    Physics,
    Florida International Univ, Miami, FL
  • Z. Dixon
    Dietetics and Nutirion,
    Florida International Univ, Miami, FL
  • V. Etienne–Levielle
    Chemistry,
    Florida International Univ, Miami, FL
  • M. Formosa
    Dietetics and Nutrition,
    Florida International Univ, Miami, FL
  • M. Saint–Louis
    Chemistry,
    Florida International Univ, Miami, FL
  • Footnotes
    Commercial Relationships  J.T. Landrum, None; R.A. Bone, None; Z. Dixon, None; V. Etienne–Levielle, None; M. Formosa, None; M. Saint–Louis, None.
  • Footnotes
    Support  NIH grants S06GM08205 and R25GM61347. Lutein esters gift of Cognis Nutrition and Health.
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1290. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.T. Landrum, R.A. Bone, Z. Dixon, V. Etienne–Levielle, M. Formosa, M. Saint–Louis; Influence of Lutein Dosage on Macular Pigment Response . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1290.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: This study investigated the effect of lutein dose, over a 120 day (d) period, on the rate of increase in macular pigment optical density (MPOD). On a double–blind basis, subjects were assigned to 3 different dosage groups, or a placebo group. Doses were 5, 10 and 20 mg/d of lutein (as esters from marigolds). Methods: MPOD was measured twice per week in each subject by flicker photometry using a 1.5° stimulus. The table shows the average rates of increase in MPOD for each group (mAU = milli–absorbance unit). Results: The 20 mg group in row 4 was composed of 25 subjects below the age of 30 (row 5) and 14 subjects over 50 (row 6). By excluding the over 50 group, the dosage groups are reasonably age–matched. They indicate a general increase in MPOD response with dose. The 10 and 20 mg groups, but not the 5 mg group, differed significantly from the placebo group (p < 0.05, 1–sided t–test). For the two age groups taking 20 mg, there was a weaker MPOD response in the older group compared with the younger (p = 0.05). Column 5 shows that with increasing dose, an increasing number of eyes exhibited a positive MPOD response. Conclusions: We conclude that in the short term, 20 mg doses are effective at raising MPOD, but smaller doses may be of marginal value.  

Keywords: macular pigment • carotenoids/carotenoid binding proteins 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×